Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels.

ClinicalTrials.gov ID: NCT00055510

Public ClinicalTrials.gov record NCT00055510. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 10:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This research study is intended to evaluate the safety and effectiveness of 3 different doses of BO-653, an investigational inhibitor of LDL cholesterol oxidation, when given orally twice a day compared to placebo (an inactive substance) in preventing restenosis (closure of vessel) within six months after stent implantation. Patients must be enrolled into this study within 24 hours after the stenting procedure. Additionally, over a 1- to 9-month post-stent period, the study will compare the safety and effectiveness of BO-653 versus placebo for measures of coronary artery vessel size by quantitative coronary angiography, major adverse cardiac events, and effects on the oxidative status of plasma lipids and other plasma components.

Study identification

NCT ID
NCT00055510
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Chugai Pharma USA
Industry
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 24, 2005

United States locations

U.S. sites
29
U.S. states
17
U.S. cities
27
Facility City State ZIP Site status
St. Luke's Medical Center Phoenix Arizona 85006 —
University of Arizona Sarver Heart Center Tucson Arizona 85724 —
Cardiovascular Associates of the Peninsula Burlingame California 94010 —
Foundation for Cardiovascular Medicine La Jolla California 92037 —
La Mesa Cardiac Center La Mesa California 91942 —
Clinical Research Center of California San Diego California 92117 —
Veterans Affairs Medical Center San Diego California 92161 —
University of Florida Health Science Center Jacksonville Florida 32209 —
Miami International Cardiology Consultants Miami Beach Florida 33140 —
Mediquest Research Group Ocala Florida 34474 —
Midwest Heart Research Foundation Lombard Illinois 60148 —
Iowa Heart Center Des Moines Iowa 50314 —
Alton Ochsner Medical Foundation New Orleans Louisiana 70121 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Baystate Medical Center Springfield Massachusetts 01199 —
Borgess Medical Center Kalamazoo Michigan 49048 —
Michigan Heart Ypsilanti Michigan 48197 —
Minneapolis Heart Institute Foundation Minneapolis Minnesota 55407 —
St. Louis University St Louis Missouri 63110 —
Nevada Cardiology Associates Las Vegas Nevada 89109 —
University of Rochester Medical Center Rochester New York 14642 —
Asheville Cardiology Associates, PA Asheville North Carolina 28803 —
Northwestern Memorial Hospital Elyria Ohio 44035 —
Oklahoma Foundation for Cardiovascular Research Oklahoma City Oklahoma 73120 —
Austin Heart Austin Texas 78756 —
IRCI Institute for Research in Cardiovascular Interventions at The Methodist DeBakey Heart Center Houston Texas 77030 —
University of Texas Health Science Center San Antonio Texas 78229-3900 —
University of Utah Salt Lake City Utah 84132 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00055510, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2005 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00055510 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →